Table 1 Demographics
Whole population N = 68 | IHC subset N = 42 | |
|---|---|---|
Age, years | ||
Median | 68.9 (19–89.7) | 69.7 (19–89.7) |
Tumor location | ||
Cervix | 7 (10%) | 4 (10%) |
Endometrium | 61 (90%) | 37 (88%) |
Missing data | 1 (2%) | |
Personal history of cancer | ||
Yes | 17 (25%) | 10 (24%) |
No | 49 (72%) | 32 (76%) |
Missing data | 2 (3%) | 0 |
Family history of cancer | ||
Yes | 21 (30%) | 12 (29%) |
No | 38 (57%) | 26 (62%) |
Missing data | 9 (13%) | 4 (9%) |
Hypertension | ||
No | 47 (69%) | 27 (64%) |
Yes | 19 (28%) | 15 (36%) |
Absence de donnée | 2 (3%) | 0 |
Diabetes | ||
No | 51 (75%) | 33 (79%) |
Yes | 11 (16%) | 6 (14%) |
Missing data | 6 (9%) | 3 (7%) |
Body Max Index (Kg/m2)) | ||
< 18 | 6 (9%) | 2 (5%) |
18–25 | 19 (27%) | 12 (28%) |
25–30 | 21 (31%) | 15 (36%) |
> 30 | 10 (15%) | 7 (17%) |
Missing data | 12 (18%) | 6 (14%) |
FIGO stage at diagnosis | ||
I | 38 (56%) Including 16 IA | 26 (62%) including 9 IA |
II | 4 (6%) | 2 (5%) |
III | 15 (22%) | 8 (19%) |
IV | 7 (10%) | 5 (12%) |
Missing data | 4 (6%) | 1 (2%) |
Lymph node status at diagnosis | ||
pN0 | 51 (75%) | 33 (78%) |
pN1 | 15 (22%) | 7 (17%) |
Missing data | 2 (3%) | 2 (5%) |
Lymphovascular invasion | ||
Yes | 29 (43%) | 19 (45%) |
No | 24 (35%) | 16 (38%) |
Missing data | 15 (22%) | 7 (17%) |